Since their discovery in 1987 [13] and 1993 [14], respectively, roles of MET and RON in CRAC have been extensively studied, which demonstrate their importance in tumor progression, malignancy, and stemness [11, 12]. The gene discussed is MET; the disease is neoplasm.